Christopher Kramer MD
banner
chriskramermd.bsky.social
Christopher Kramer MD
@chriskramermd.bsky.social
Chief, CV Division, University of Virginia Health, CV imager, and President, ACC. Husband and father of 2 successful men #CardioSky #MedSky
Reposted by Christopher Kramer MD
✨️Honored to represent #UVA and speak at the Indian Association of Charlottesville's #Diwali celebration 🎆 on #SouthAsian heart health awareness! Grateful for the opportunity to engage with the community on prevention and early action🫀💪🏽🪔 @prodriguezmd.bsky.social @chriskramermd.bsky.social
October 28, 2025 at 2:16 AM
June 19, 2025 at 10:39 PM
Reposted by Christopher Kramer MD
@cardiosky.bsky.social
Thank you @scct-heart.bsky.social for this incredible honor! Humbled to have received this! @prodriguezmd.bsky.social @chriskramermd.bsky.social
Congratulations to @nhosadurg.bsky.social on being named the inaugural recipient of SCCT’s Chinnaiyan Catalyst Award for Women’s Cardiovascular Health Research! Her work on coronary CT and hypertensive disorders of pregnancy is breaking new ground. #SCCT2025 #CardioSky

scct.org/page/Chinnai...
June 12, 2025 at 4:18 PM
@bsky.social
Inspiring to see ACC President @chriskramermd.bsky.social welcome more than 40 new Fellows to the @accintouch.bsky.social during #ACCAsia in Singapore.
May 15, 2025 at 2:45 PM
@bsky.social
ACC President @chriskramermd.bsky.social kicks off #ACCAsia opening session, reiterating the @accintouch.bsky.social commitment to mitigating the global burden of CV disease and transforming CV care for all through science, innovation and sharing of knowledge.
May 11, 2025 at 2:26 AM
Had the privilege of testifying before the Labor and HHS subcommittee of the House Appropriations Committee on behalf of the #ACCinTouch #AmericanCollegeofCardiology on funding of the HEARTS act (AED’s in schools) as well as for NIH and CDC funding for cardiovascular research
April 10, 2025 at 9:36 AM
Reposted by Christopher Kramer MD
Congratulations to new #ACCPresident Christopher M. Kramer, MD, FACC! Inspired by a movie classic, he shared: “Today I want to talk to you about two Fantastic Voyage-Related themes: innovation and mentorship.”

💬 bit.ly/41RJlF6 @ChrisKramerMD #ACC25 #ACCLeadership
March 31, 2025 at 10:15 PM
Reposted by Christopher Kramer MD
March 31, 2025 at 11:01 PM
Reposted by Christopher Kramer MD
At #ACC25, Dr. Milton Packer & colleagues present a new secondary analysis from the #SUMMIT trial. They find tirzepatide's #heartfailure benefits extended to patients with #CKD, and that #tirzepatide also improved renal function bit.ly/4iRQJX8

#JACC #HFpEF @chriskramermd.bsky.social
March 31, 2025 at 3:20 PM
Reposted by Christopher Kramer MD
I’m so proud of my great friend and colleague, Dr Katie Berlacher, who has organized an innovative and exciting @accintouch.bsky.social annual meeting.
March 29, 2025 at 1:35 PM
Reposted by Christopher Kramer MD
Exciting! #STRIDE trial just presented at #ACC25 @accintouch.bsky.social . #Semaglutide improved mean walking distance, symptoms, major limb events & quality of life in patients with #T2D & #PAD. We have a new drug now to help PAD patients! #CardioSky
March 29, 2025 at 3:13 PM
Reposted by Christopher Kramer MD
💡 #Semaglutide is the first therapy to ⬇️ #MACE, improve cardiometabolic and kidney outcomes and improves walking capacity, symptoms, and related #QoL in patients with #cvPAD and #T2D

#ACC25 #JACCJournals #CardioSky
Dr. Marc Bonaca on the effect of once-weekly subcutaneous #semaglutide on functional capacity in people with #T2D and #cvPAD

#ACC25 #JACCJournals
March 29, 2025 at 3:19 PM
Reposted by Christopher Kramer MD
New 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guidelines up the ante on LDL-C management for secondary ACS prevention and suggest add-on lipid lowering therapy with max tolerated statin tx – check out the update here! #CardioSky #MedSky #ClinicalGuidelines @accintouch.bsky.social
March 17, 2025 at 9:02 PM
Reposted by Christopher Kramer MD
"The whole thing about gene therapy is you need to get enough gene in the right place in a site-specific manner in a safe process."

Jonathan Lindner, MD, is working to improve the safety and efficacy of gene therapies. Read more below!

#cardiology #cardiosky #medsky #genetherapy
Jonathan Lindner, MD, works towards improved gene therapies – Robert M. Berne Cardiovascular Research Center
www.cvrc.virginia.edu
March 17, 2025 at 1:27 PM
Reposted by Christopher Kramer MD
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity🔓
www.ahajournals.org/doi/10.1161/...
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity | Circulation
BACKGROUND: Patients with heart failure with preserved ejection fraction and obesity have significant disability and frequent exacerbations of heart failure. We hypothesized that tirzepatide, a long-a...
www.ahajournals.org
March 11, 2025 at 9:49 AM
Reposted by Christopher Kramer MD
Cardiologists, patients and the entire CV community spoke—ABMS didn’t listen. We are profoundly disappointed by the decision to deny the creation of a new #CVBoard.

More: bit.ly/4ikCBoI

#CardioSky @americanheart.bsky.social @hfsa.bsky.social @scainews.bsky.social @heartrhythmsociety.bsky.social
February 28, 2025 at 8:06 PM